C1q aggregate binding for the determination of anti-complementary activity of immunoglobulin products

Biologicals

Volumn 39, Issue 1, 2011, Pages 38-42

  Georgakopoulos, Thanae ^a   Tatford, Owen C ^a   Gurevich, Vladimir ^a   Bertolini, Joseph ^a  

^a Research and Development Department   (Australia)

Author keywords

Aggregates; Anti complementary activity; C1q binding; Complement; Immunoglobulin

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4D; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN G;

ACCURACY; ARTICLE; BINDING ASSAY; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAT TREATMENT; HUMAN; IMMUNOGLOBULIN AGGREGATE; IN VITRO STUDY; PH; PRIORITY JOURNAL; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TURBIDITY; VALIDATION STUDY;

COMPLEMENT ACTIVATION; COMPLEMENT C1Q; COMPLEMENT INACTIVATOR PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HOT TEMPERATURE; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; IMMUNOGLOBULINS, INTRAVENOUS; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS;

EID: 79551550343     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2010.11.002     Document Type: Article

References (11)

1. Chi E.Y., Krishnan S., Randolph T.W., Carpenter J.F. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm Res 2003, 20:1325-1336.
2. Test for anticomplementary activity of immunoglobulin in European Pharmacopoeia, (Monograph 2.6.17) 2007, vol. 1. European Directorate for the Quality of Medicines & HealthCare, Strasbourg. Ed. 6.
3. Buchacher A., Schluga P., Mullner J., Schreiner M., Kannicht C., Weinberger J. Anticomplementary activity of IVIG concentrates - important assay parameters and impact of IgG polymers. Vox Sang 2010, 98:e209-e218.
4. Doekes G., Vanes L.A., Daha M.R. Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates. Immunology 1982, 45:705-713.
5. Rieben R., Roos A., Muizert Y., Tinguely C., Gerritsen A.F., Daha M.R. Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood 1999, 3:942-951.
6. Mollnes T.E., Andreassen I.H., Hogasen K., Hack C.E., Harboe M. Effect of whole and fractionated intravenous immunoglobulin on complement in vitro. Mol Immunol 1997, 34:719-729.
7. Spycher M., Matozan K., Minnig K., Zehnder R., Miescher S., Hoefferer L., et al. In vitro comparison of the complement-scavenging capacity of different intravenous immunoglobulin preparations. Vox Sang 2009, 97:348-354.
8. Ramasamy I., Tran E., Farrugia A. Measurement of anticomplementary activity in therapeutic intravenous immunoglobulin preparations. Biologicals 1997, 25:87-92.
9. Bridonneau P., Marcilly H., Vernois-Martin M., Goigoux P., Bourdel V., Laulan A., et al. Liquid pasteurization of an immunoglobulin preparation without stabilizer: effects on its biological and biochemical properties. Vox Sang 1996, 70:203-209.
10. Seiler F.R., Peukert A., Kanzy E.J. Comparison of several in vitro assay methods for the quantitative determination of complement consumption ('binding') by gammaglobulin preparations. Developments in biological standardisation 1979, vol. 44:153-163. The international association of biological standardisation. S. Basel, A.G. Karger (Eds.).
11. Gronski P., Kanzy E.J., Ronneberger R., Geursen R., Seiler F.R. Quality criteria for I.V. immunoglobulins: importance of tests and product properties. Developments in biological standardisation 1987, vol. 67:239-256. The international association of biological standardisation. S. Basel, A.G. Karger (Eds.).